<DOC>
	<DOCNO>NCT03055806</DOCNO>
	<brief_summary>A Phase 2b , 8-week , double-blind , placebo-controlled , parallel group study evaluate effect 3 different dose level IX-01 IELT patient-reported outcome men lifelong PE . Men self-reported lifelong PE ( International Society Sexual Medicine ( ISSM ) definition ) stable heterosexual relationship undergo 4-week run-in period ask attempt intercourse least 4 time . Men IELT ≤ 1 minute least 75 % attempts intercourse no-treatment run-in period randomize double-blind phase study . In double-blind phase study , men ask take study drug 1 6 hour prior sexual activity . Men partner ask attempt intercourse minimum 8 time 8 week double-blind study treatment . The patient partner record IELT occasion use stopwatch .</brief_summary>
	<brief_title>IX-01 Effect Intravaginal Ejaculatory Latency Time ( IELT ) , Patient Reported Outcomes Safety Men With Premature Ejaculation ( PE )</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>1 . Men age ≥18 year ≤60 year stable ( ≥6 month ) heterosexual relationship lifelong PE . 2 . Premature ejaculation ≤1 minute ≥75 % attempt sexual intercourse runin period . 3 . Meets aspects ISSM definition . 4 . Patient partner willing attempt intercourse least 4 time runin period least 8 additional time doubleblind part study . 5 . Partner plan pregnancy willing use contraception ( unless childbearing potential , e.g , surgically sterilize ) . 6 . Willing limit use alcohol day take study drug . 7 . Capable give write informed consent . 1 . IELT value &gt; 2 minute runin period . 2 . &lt; 4 attempt sexual intercourse runin period . 3 . Any patient rate control ejaculation fair , good , good . 4 . Any patient rate ejaculationrelated `` personal distress '' `` '' `` little bit '' . 5 . Erectile Dysfunction . 6 . Concomitant use phosphodiesterase type 5 ( PDE5 ) inhibitor , selective serotonin reuptake inhibitor ( SSRIs ) /selective serotonin norepinephrine reuptake inhibitor ( SSNRIs ) , monoamine oxidase inhibitor , alpha blocker , 5alpha reductase inhibitor , topical anesthetic , and/or tramadol . 7 . History ( last 6 month ) use Botox similar product treat PE . 8 . Has receive IX01 previous clinical study . 9 . Unwilling stop treatment PE ( include limited pharmacological , sex therapy , psychotherapy multiple condom , prior masturbation ) . 10 . Any sexual disorder patient partner could interfere result . 11 . Any current sexually transmitted disease . 12 . Any major medical condition patient could interfere ability sexual activity and/or require hospital treatment . 13 . Body mass index ( BMI ) &gt; 40 kg/m2 weight &lt; 60 kg . 14 . Participation clinical drug study anytime 30 day prior screen . 15 . Human immunodeficiency virus ( HIV ) , hepatitis B . 16 . History prostate disease clinically significant prostate disease . 17 . History myocardial infarction , coronary bypass surgery , coronary artery angioplasty , unstable angina , clinically evident congestive heart failure , cardiac pacemaker , cerebrovascular accident . 18 . Known suspected history significant cardiac arrhythmia . 19 . History druginduced allergic reaction include skin reaction . 20 . Significant psychiatric disease and/or risk suicidal tendency . 21 . History evidence recent alcohol drug abuse .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sex</keyword>
	<keyword>Sexual Dysfunction</keyword>
	<keyword>IX-01</keyword>
</DOC>